etofylline clofibrate has been researched along with Hyperlipoproteinemia Type II in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Metz, G; Specker, M; Ziegler, WJ | 1 |
| Vorberg, G; Ziegler, WJ | 1 |
| Ditschuneit, H; Ditschuneit, HH; Hutt, V; Klör, HU | 1 |
| Chmela, Z; Hrbková, M; Hrebícek, J; Skottová, N | 1 |
| Klimes, I; Langrová, H; Linke-Cvrkalová, A; Pleváková, L; Rajecová, E; Rychnavská, E; Seböková, E | 1 |
| Augustin, J; Gnasso, A; Haberbosch, W; Ziegler, W | 1 |
2 trial(s) available for etofylline clofibrate and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Topics: Clofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents | 1980 |
[Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged | 1980 |
4 other study(ies) available for etofylline clofibrate and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Clinical effects and tolerance of etofylline clofibrate].
Topics: Clofibrate; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents | 1980 |
[Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipids; Male; Middle Aged | 1995 |
[Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Topics: Clofibrate; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged | 1995 |
The effect of etophylline clofibrate on HDL subfractions.
Topics: Adult; Aged; Apolipoproteins; Cholesterol, LDL; Clofibrate; Female; Heparin; Humans; Hyperlipoproteinemia Type II; Lipolysis; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Male; Middle Aged; Ultracentrifugation | 1985 |